{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:52:56Z","timestamp":1794646376419,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s13577-017-0187-5","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T14:38:56Z","timestamp":1513953536000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3"],"prefix":"10.1007","volume":"31","author":[{"given":"Dongsheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"issue":"6","key":"187_CR1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;39(6):889\u2013909.","journal-title":"Neuron"},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci. 2005;28:57\u201387. doi:\n                        10.1146\/annurev.neuro.28.061604.135718\n                        \n                    .","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"187_CR3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","volume":"4","author":"J Jankovic","year":"2008","unstructured":"Jankovic J, Aguilar LG. Current approaches to the treatment of Parkinson\u2019s disease. Neuropsychiatric disease and treatment. 2008;4(4):743\u201357.","journal-title":"Neuropsychiatric disease and treatment"},{"issue":"9996","key":"187_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912. doi:\n                        10.1016\/S0140-6736(14)61393-3\n                        \n                    .","journal-title":"Lancet"},{"issue":"5","key":"187_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","volume":"14","author":"J Pagonabarraga","year":"2015","unstructured":"Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson\u2019s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015;14(5):518\u201331. doi:\n                        10.1016\/S1474-4422(15)00019-8\n                        \n                    .","journal-title":"Lancet Neurol"},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du RH, Qiao C, Jiang CY, Zhang KZ, Ding JH, Hu G. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener. 2016;11:28. doi:\n                        10.1186\/s13024-016-0094-3\n                        \n                    .","journal-title":"Mol Neurodegener"},{"issue":"4","key":"187_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps. Apoptosis: Int J Program Cell Death. 2009;14(4):478\u2013500. doi:\n                        10.1007\/s10495-008-0309-3\n                        \n                    .","journal-title":"Apoptosis: Int J Program Cell Death"},{"key":"187_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2017.02.001","author":"B Kaur","year":"2017","unstructured":"Kaur B, Prakash A. Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson\u2019s disease in rats. Pathophysiol: Off J Int Soc Pathophysiol. 2017;. doi:\n                        10.1016\/j.pathophys.2017.02.001\n                        \n                    .","journal-title":"Pathophysiol: Off J Int Soc Pathophysiol"},{"issue":"1\u20132","key":"187_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994;165(1\u20132):208\u201310.","journal-title":"Neurosci Lett"},{"issue":"2","key":"187_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994;180(2):147\u201350.","journal-title":"Neurosci Lett"},{"issue":"6","key":"187_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821\u201332. doi:\n                        10.1016\/j.cell.2010.01.040\n                        \n                    .","journal-title":"Cell"},{"issue":"7","key":"187_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377. doi:\n                        10.1038\/nri3705\n                        \n                    .","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"187_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","volume":"117","author":"D Marcellino","year":"2010","unstructured":"Marcellino D, Suarez-Boomgaard D, Sanchez-Reina MD, Aguirre JA, Yoshitake T, Yoshitake S, Hagman B, Kehr J, Agnati LF, Fuxe K, Rivera A. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson\u2019s disease: studies with the P2X(7) receptor antagonist A-438079. J Neural Transm. 2010;117(6):681\u20137. doi:\n                        10.1007\/s00702-010-0400-0\n                        \n                    .","journal-title":"J Neural Transm"},{"issue":"8","key":"187_CR14","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 Regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci. 2016;36(8):2383\u201390. doi:\n                        10.1523\/JNEUROSCI.3900-15.2016\n                        \n                    .","journal-title":"J Neurosci"},{"issue":"5","key":"187_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ana.23967","volume":"74","author":"CS Moore","year":"2013","unstructured":"Moore CS, Rao VT, Durafourt BA, Bedell BJ, Ludwin SK, Bar-Or A, Antel JP. miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization. Ann Neurol. 2013;74(5):709\u201320. doi:\n                        10.1002\/ana.23967\n                        \n                    .","journal-title":"Ann Neurol"},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fphys.2015.00040","volume":"6","author":"GD Femminella","year":"2015","unstructured":"Femminella GD, Ferrara N, Rengo G. The emerging role of microRNAs in Alzheimer\u2019s disease. Front Physiol. 2015;6:40. doi:\n                        10.3389\/fphys.2015.00040\n                        \n                    .","journal-title":"Front Physiol"},{"issue":"2","key":"187_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/bpa.12267","volume":"26","author":"H Wang","year":"2016","unstructured":"Wang H, Ye Y, Zhu Z, Mo L, Lin C, Wang Q, Wang H, Gong X, He X, Lu G, Lu F, Zhang S. MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson\u2019s disease by targeting to bims. Brain Pathol. 2016;26(2):167\u201376. doi:\n                        10.1111\/bpa.12267\n                        \n                    .","journal-title":"Brain Pathol"},{"issue":"20","key":"187_CR18","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","volume":"22","author":"ED Koval","year":"2013","unstructured":"Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF, Miller TM. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet. 2013;22(20):4127\u201335. doi:\n                        10.1093\/hmg\/ddt261\n                        \n                    .","journal-title":"Hum Mol Genet"},{"issue":"4","key":"187_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-014-1255-5","volume":"127","author":"S Nuber","year":"2014","unstructured":"Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E. Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD. Acta Neuropathol. 2014;127(4):477\u201394. doi:\n                        10.1007\/s00401-014-1255-5\n                        \n                    .","journal-title":"Acta Neuropathol"},{"issue":"4587","key":"187_CR20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219(4587):979\u201380.","journal-title":"Science"},{"issue":"1\u20132","key":"187_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000452521","volume":"40","author":"Y Liu","year":"2016","unstructured":"Liu Y, Liao S, Quan H, Lin Y, Li J, Yang Q. Involvement of microRNA-135a-5p in the protective effects of hydrogen sulfide against Parkinson\u2019s disease. Cell Physiol Biochem. 2016;40(1\u20132):18\u201326. doi:\n                        10.1159\/000452521\n                        \n                    .","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"187_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jneumeth.2007.08.024","volume":"167","author":"AB Reksidler","year":"2008","unstructured":"Reksidler AB, Lima MM, Dombrowski P, Andersen ML, Zanata SM, Andreatini R, Tufik S, Vital MA. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson\u2019s disease. J Neurosci Methods. 2008;167(2):268\u201377. doi:\n                        10.1016\/j.jneumeth.2007.08.024\n                        \n                    .","journal-title":"J Neurosci Methods"},{"issue":"5842","key":"187_CR23","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317(5842):1220\u20134. doi:\n                        10.1126\/science.1140481\n                        \n                    .","journal-title":"Science"},{"issue":"17","key":"187_CR24","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem. 2010;285(17):12726\u201334. doi:\n                        10.1074\/jbc.M109.086827\n                        \n                    .","journal-title":"J Biol Chem"},{"issue":"8","key":"187_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/febs.13238","volume":"282","author":"SY Kwak","year":"2015","unstructured":"Kwak SY, Kim BY, Ahn HJ, Yoo JO, Kim J, Bae IH, Han YH. Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B. FEBS J. 2015;282(8):1512\u201325. doi:\n                        10.1111\/febs.13238\n                        \n                    .","journal-title":"FEBS J"},{"issue":"1","key":"187_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI58849","volume":"122","author":"L Jiang","year":"2012","unstructured":"Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, Fang L, Yan X, He M, Li J, Li M. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB\/IkappaBalpha negative feedback loop. J Clin Investig. 2012;122(1):33\u201347. doi:\n                        10.1172\/JCI58849\n                        \n                    .","journal-title":"J Clin Investig"},{"issue":"1","key":"187_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA. Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol. 2000;166(1):127\u201335. doi:\n                        10.1006\/exnr.2000.7483\n                        \n                    .","journal-title":"Exp Neurol"},{"issue":"1","key":"187_CR28","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One. 2013;8(1):e55375. doi:\n                        10.1371\/journal.pone.0055375\n                        \n                    .","journal-title":"PLoS One"},{"issue":"4","key":"187_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2007.04.005","volume":"26","author":"CA Dinarello","year":"2007","unstructured":"Dinarello CA. A signal for the caspase-1 inflammasome free of TLR. Immunity. 2007;26(4):383\u20135. doi:\n                        10.1016\/j.immuni.2007.04.005\n                        \n                    .","journal-title":"Immunity"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-017-0187-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-017-0187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-017-0187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T10:17:22Z","timestamp":1521022642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-017-0187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1007\/s13577-017-0187-5","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]}}}